Chester County News and Community Website
MALVERN, PA — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, announced FDA authorization to proceed with …
Read More
MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy …
Read More
DEVON, PA — Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, announced positive top line results from the exploratory, …
Read More
WAYNE, PA — Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, recently announced the peer-reviewed publication of its Tack Optimized Balloon Angioplasty (TOBA) III 12-month clinical trial …
Read More
HARRISBURG, PA — Pennsylvania’s Department of Health is distributing the investigational antiviral medication, remdesivir, to treat patients in the hospital with COVID-19. The federal government distributed the first shipment of …
Read More MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy …
Read More
SILVER SPRING, MD — The U.S. Food and Drug Administration is taking important actions to help accelerate the development of prevention and treatment options for COVID-19 by providing new guidance …
Read More
BERWYN, PA — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, announced today that the protocol …
Read More
WAYNE, PA — Cagent Vascular, a developer of serration technology for vessel dilatation in cardiovascular disease interventions, announced FDA 510(k) Clearance of its Serranator® PTA Serration Balloon Catheter for treating …
Read More
WAYNE, PA — Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, this week announced it received U.S. Food and Drug Administration (FDA) approval for …
Read More